Accessibility tools
cuh logo

Dr Pippa Corrie - Publications

Wan JCM, Heider K, Gale D, Murphy S, Fisher E, Mouliere F, Ruiz-Valdepenas A, Santonja A, Morris J, Chandrananda D, Marshall A, Gill AB, Chan PY, Barker E, Young G, Cooper WN, Hudecova I, Marass F, Mair R, Brindle KM, Stewart GD, Abraham J, Caldas C, Rassl DM, Rintoul RC, Alifrangis C, Middleton MR, Gallagher FA, Parkinson C, Durrani A, McDermott U, Smith CG, Massie C, Corrie PG and Rosenfeld N. ctDNA monitoring using patient-specific sequencing and integration of variant reads. Sci Trans Med 2020; 12 (548) eaaz8084.
View publication
17 Jun 2020
Welsh SJ and Corrie PG. Biomarkers predicting for response and relapse with melanoma systemic therapy. Acta Dermato-Venereol 2020; 100: 300-8.
View publication
03 Jun 2020
Corrie PG, Qian W, Basu B, Valle JW, Falk S, lwuji C, Wasan H, Palmer D, Scott-Brown M, Wadsley J, Arif S, Bridgewater J, Propper D, Gillmore R, Gopinathan A, Skells R, Bundi R, Brais R, Dalchau K, Bax L, Chhabra A, Machin A, Dayim A, McAdam K, Cummins S, Wall L, Ellis R, Anthoney A, Evans J, Ma YT, Isherwood C, Neesse A, D Tuveson, Jodrell DI. Scheduling nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic adenocarcinoma. Br J Cancer 2020; 122: 1760-68.
View publication
30 Apr 2020
PG Corrie, AM Moody, G Armstrong, S Nolasco, S Lao-Sirieix, L Bavister, AT Prevost, R Parker, R Sabes-Figuera, P McCrone, H Balsdon, K McKinnon, A Hounsell, B O’Sullivan, SIG Barclay. Is community treatment best? A randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery. Br J Cancer 2013; 109:1549-1555.
View publication
23 Aug 2019
Corrie P, Matrisian L, Poon JO. Pancreatic cancer – current landscape. Oncol Hematol Rev (US) 2019;15 (Suppl.1)
View publication
06 Sep 2019
Corrie PG, Marshall A, Nathan PD, Lorigan P , Gore M, Tahir S, Faust G, Kelly CG, Marples M, Danson SJ, Marshall M, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Goodman A, Dalgleish A, Martin-Clavijo A, Westwell S, Casasola R, Chao D, Maraveyas A, Patel P,Ottensmeier CH, Farrugia D, Humphreys A, Eccles B, Young G, Barker EO, Harman C, Weiss M, Myers KA, Chhabra A, Rodwell SH, Dunn JA, Middleton MR, on behalf of the AVAST-M Investigators. Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals Oncol 2018; 29: 1843-52.
View publication
01 Aug 2018
Lipplaa A, Fernandes R, Marshall A, Lorigan P, Dunn J, Myers KA, Barker E, Newton-Bishop J, Middleton MR, Corrie PG. 25-hydroxyvitamin D serum levels in patients with resected melanoma at high risk of recurrence. Br J Cancer 2018 119; 793-800.
View publication
23 Jul 2018
E Liniker, M Harrison, JMJ Weaver, N Agrawal, A Chhabra, V Kingshott, S Bailey, TGG Eisen, PG Corrie. Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-10). Br J Cancer 2013; 109: 2051-2057.
View publication
15 Oct 2013
Board R, Smittenaar R, Lawton S, Li H, Juwa G, Chao D, Corrie P. Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018. Int J Cancer 2020; doi.org/10.1002/ijc.33266.
View publication
24 Aug 2020
Rabbie R, Ferguson P, Wong K, Couturier D-L, Moran U, Turner C, Emanuel P, Haas K, Saunus JM, Davidson MR, Lakhani SR, Shivalingam B, Long GV, Parkinson C, Osman I, Scolyer RA, Corrie P, Adams DJ. The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. Br J Cancer 2020 (published online 07 October 2020)
View publication
07 Oct 2020